What is the optimal first line antiretroviral therapy in resource-limited settings?

C. Kenyon; R. Colebunders

doi:10.1371/journal.pmed.1001291

What is the optimal first line antiretroviral therapy in resource-limited settings?

C. Kenyon
, R. Colebunders

Research output: Contribution to journal › Editorial › peer-review

55 Downloads (Pure)

Original language	English
Article number	e1001291
Journal	PLoS Medicine
Volume	9
Issue number	8
ISSN	1549-1676
DOIs	https://doi.org/10.1371/journal.pmed.1001291
Publication status	Published - 2012

Keywords

Viral diseases
HIV
AIDS
HAART
Antiretrovirals
First-line drugs
Combination therapy
Efavirenz
Lamivudine
Zidovudine
Atazanavir
Didanosine
Emtricitabine
Tenofovir
Efficacy
Toxicity
Developing countries

Access to Document

10.1371/journal.pmed.1001291Licence: CC BY

2012pmede1001291Final published version, 62.1 KB

Cite this

@article{324e39cea38943cfaad77c6ad5131358,

title = "What is the optimal first line antiretroviral therapy in resource-limited settings?",

keywords = "Viral diseases, HIV, AIDS, HAART, Antiretrovirals, First-line drugs, Combination therapy, Efavirenz, Lamivudine, Zidovudine, Atazanavir, Didanosine, Emtricitabine, Tenofovir, Efficacy, Toxicity, Developing countries",

author = "C. Kenyon and R. Colebunders",

note = "M1 - PLoS Med",

year = "2012",

doi = "10.1371/journal.pmed.1001291",

language = "English",

volume = "9",

journal = "PLoS Medicine",

issn = "1549-1676",